Header Logo

Connection

Andriy Yabluchanskiy to Poly(ADP-ribose) Polymerase Inhibitors

This is a "connection" page, showing publications Andriy Yabluchanskiy has written about Poly(ADP-ribose) Polymerase Inhibitors.
  1. Treatment with the poly(ADP-ribose) polymerase inhibitor PJ-34 improves cerebromicrovascular endothelial function, neurovascular coupling responses and cognitive performance in aged mice, supporting the NAD+ depletion hypothesis of neurovascular aging. Geroscience. 2019 10; 41(5):533-542.
    View in: PubMed
    Score: 0.161
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.